This Article Full Text Full Text (PDF) All Versions of this Article: 18/7/1697    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bazuine, M. Articles by Maassen, J. A. Search for Related Content PubMed PubMed Citation Articles by Bazuine, M. Articles by Maassen, J. A.

Mitogen-Activated Protein Kinase (MAPK) Phosphatase-1 and -4 Attenuate p38 MAPK during Dexamethasone-Induced Insulin Resistance in 3T3-L1 Adipocytes

Department of Molecular Cell Biology (M.B., F.C., R.S.J.T., R.C.H., J.A.M.), Leiden University Medical Center, 2333 AL Leiden, The Netherlands; and Unité Mixte de Recherche 6548 (F.C.), Université de Nice, 06108 Nice, France

Address all correspondence and requests for reprints to: Dr. J. A. Maassen, Signal Transduction Laboratory, Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, PO Box 9503, 2333 AL Leiden, The Netherlands. E-mail: J.A.Maassen{at}LUMC.NL.

Prolonged use of glucocorticoids induces pronounced insulin resistance in vivo. In vitro, treatment of 3T3-L1 adipocytes with dexamethasone for 48 h reduces the maximal level of insulin- and stress (arsenite)-induced glucose uptake by approximately 50%. Although phosphatidylinositol 3-kinase signaling was slightly attenuated, phosphorylation of its downstream effectors such as protein kinase B and protein kinase C- remained intact. Nor was any effect of dexamethasone treatment observed on insulin- or arsenite-induced translocation of glucose transporter 4 (GLUT4) toward the plasma membrane. However, for a maximal response to either arsenite- or insulin-induced glucose uptake in these cells, functional p38 MAPK signaling is required. Dexamethasone treatment markedly attenuated p38 MAPK phosphorylation coincident with an up-regulation of the MAPK phosphatases MKP-1 and MKP-4. Employing lentivirus-mediated ectopic expression in fully differentiated 3T3-L1 adipocytes demonstrated a differential effect of these phosphatases: whereas MKP-1 was a more potent inhibitor of insulininduced glucose uptake, MKP-4 more efficiently inhibited arsenite-induced glucose uptake. This coincided with the effects of these phosphatases on p38 MAPK phosphorylation, i.e. MKP-1 and MKP-4 attenuated p38 MAPK phosphorylation by insulin and arsenite, respectively. Taken together, these data provide evidence that in 3T3-L1 adipocytes dexamethasone inhibits the activation of the GLUT4 in the plasma membrane by a p38 MAPK-dependent process, rather than in a defect in GLUT4 translocation per se.

NURSA Molecule Pages Link:

Ligands:   Dexamethasone  |  RU486

This article has been cited by other articles:

				G. Li, I. S. Ali, and R. W. Currie Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27 Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H74 - H87. [Abstract] [Full Text] [PDF]

				K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940. [Abstract] [Full Text] [PDF]

				V. Gupta, N. Awasthi, and B. J. Wagner Specific Activation of the Glucocorticoid Receptor and Modulation of Signal Transduction Pathways in Human Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1724 - 1734. [Abstract] [Full Text] [PDF]

				D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF]

				T. Hiragun, Z. Peng, and M. A. Beaven Cutting Edge: Dexamethasone Negatively Regulates Syk in Mast Cells by Up-Regulating Src-Like Adaptor Protein J. Immunol., August 15, 2006; 177(4): 2047 - 2050. [Abstract] [Full Text] [PDF]

				H. Xu, Q. Yang, M. Shen, X. Huang, M. Dembski, R. Gimeno, L. A. Tartaglia, R. Kapeller, and Z. Wu Dual Specificity MAPK Phosphatase 3 Activates PEPCK Gene Transcription and Increases Gluconeogenesis in Rat Hepatoma Cells J. Biol. Chem., October 28, 2005; 280(43): 36013 - 36018. [Abstract] [Full Text] [PDF]

				S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes J. Endocrinol., June 1, 2005; 185(3): R1 - R8. [Abstract] [Full Text] [PDF]

				M. Bazuine, F. Carlotti, M. J. W. E. Rabelink, J. Vellinga, R. C. Hoeben, and J. A. Maassen The p38 Mitogen-Activated Protein Kinase Inhibitor SB203580 Reduces Glucose Turnover by the Glucose Transporter-4 of 3T3-L1 Adipocytes in the Insulin-Stimulated State Endocrinology, April 1, 2005; 146(4): 1818 - 1824. [Abstract] [Full Text] [PDF]

				T. Hiragun, Z. Peng, and M. A. Beaven Dexamethasone Up-Regulates the Inhibitory Adaptor Protein Dok-1 and Suppresses Downstream Activation of the Mitogen-Activated Protein Kinase Pathway in Antigen-Stimulated RBL-2H3 Mast Cells Mol. Pharmacol., March 1, 2005; 67(3): 598 - 603. [Abstract] [Full Text] [PDF]